![]() My recent approach includes anticipating swings in momentum in a diversified portfolio. Usually, I make more good investments than bad investments, since December 2007 when I felt like cashing out but got talked out of trading with what my instincts and hunches told me to do. That's why I manage an entire portfolio with direct and indirect hedges all over the place, usually involving between 18 and 24 equities plus a cash position that stabilizes the portfolio AND stores enough ammo that I'm always prepared to pull the trigger. ![]() That's why it pays to keep track of volatility metrics. Sure, I could be wrong on one or both investments, and in timing, and in high volatility equities it's difficult to time trades. Long BNTX, NVAX, both of which have produced substantial realized and unrealized gains for me, in positions that are substantially funded with the house's money Thanks for your well-wishes. ![]() Wondering how many commenters have actually put money into the COVID-19 vaccine/treatment/testing sector. US approval for mixed flu and COVID-19 vaccine us.Īfter a year and a half of investing in COVID-related biotech, I've learned to expect huge news-driven volatility in both individual and related equities, including the recent enthusiasm for Merck's new mutagenic treatment product and the over-reactive negative effects on vaccine makers. I bought some more NVAX shares today, adding to the position I already have, because I expect share price to grow with multiple approvals and catalysts in the weeks and months to come. Obviously, there will be some more time before NVAX pays off, so we'll see. ![]() I'm catching a lot of flack for previous comments. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |